Drugs / C326
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00353756 | Sep 2006 → Sep 2007 | Crohn disease | Avidia | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | C326 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00353756 ↗ |
| Action | Inhibit | “C326, a new inhibitor of IL-6” NCT00353756 ↗ |
| Modality | Protein / enzyme biologic | “IL-6 Inhibitory Avimer protein” NCT00353756 ↗ |
| Route | Intravenous | “intravenous infusions of C326 or matching placebo” NCT00353756 ↗ |